Get the Daily Brief
Latest Biotech News
Kriya Therapeutics Raises $313M to Advance Gene Therapy Pipeline
Kriya Therapeutics, a U.S.-based gene therapy company, has completed a $313 million Series financing, one of the largest private biotech fundraises of the year. The company focuses on developing...
Adaptive Biotechnologies and Genentech End $2B Cancer Cell Therapy Collaboration
After over six years of partnership, Adaptive Biotechnologies and Genentech are winding down their $2 billion strategic collaboration focused on personalized cancer cell therapies using T cell...
Skyhawk Therapeutics Inks $2B Neurology RNA Splicing Deal with Merck KGaA
Skyhawk Therapeutics announced a newly formed RNA splicing-focused collaboration with Merck KGaA valued at up to $2 billion. The partnership targets neurological diseases, with Skyhawk deploying...
Stealth BioTherapeutics Resubmits FDA Application for Rare Barth Syndrome Drug
Stealth BioTherapeutics has resubmitted its regulatory application for an investigational therapy targeting Barth syndrome, an ultra-rare genetic disorder, following an FDA rejection earlier in...
Anocca Secures $46M to Advance TCR Cell Therapy for Pancreatic Cancer
Swedish biotech Anocca AB has raised $46 million to fund a phase I clinical trial testing its CRISPR-edited T-cell receptor (TCR) immunotherapy targeting KRAS mutations in pancreatic cancer. The...
Breakthrough in Lipid Nanoparticle Design via AI Accelerates RNA Therapies
Researchers at MIT have developed an AI-driven approach using a transformer-based neural network named Composite Material Transformer (COMET) to design optimized lipid nanoparticles (LNPs) for RNA...
Neuralink Files as Small Disadvantaged Business Despite $9B Valuation
Elon Musk’s brain-computer interface company, Neuralink, has labeled itself a “small disadvantaged business” (SDB) in an April federal filing, despite recently raising $650 million at a $9 billion...
Clinical Progress in Novel Immunotherapies and Cancer Targets
Recent clinical developments highlight advances in oncology therapeutics. A Moffitt Cancer Center study identifies combination therapies to overcome immunotherapy resistance in melanoma, while...
Advances in Prenatal Diagnostics and Pediatric Disease Insights
Innovations in prenatal and pediatric medicine continue to emerge. The discovery of the “tulip sign” as an acoustic marker aids hypospadias detection in prenatal ultrasounds. Studies link prenatal...
Novo Nordisk’s Wegovy Expands FDA Label to Fatty Liver Disease MASH
The U.S. Food and Drug Administration has granted accelerated approval for Novo Nordisk’s GLP-1 agonist Wegovy to treat metabolic dysfunction-associated steatohepatitis (MASH), a prevalent form of...
Genentech Ends Cell Therapy Collaboration with Adaptive Biotechnologies
Genentech and Adaptive Biotechnologies have agreed to terminate their strategic collaboration focused on cancer cell therapy development, originally launched in 2018 and potentially worth up to $2...
Kriya Therapeutics Raises $313 Million for Gene Therapy Pipeline Expansion
Gene therapy company Kriya Therapeutics secured a $313 million equity financing, one of 2025’s largest private biotech rounds. The funds will support the advancement of Kriya’s pipeline of nine...
Reunion Neuroscience’s Psychedelic Drug Advances to Late-Stage Trials for Postpartum Depression
Reunion Neuroscience reported positive Phase 2 results for its short-acting psychedelic prodrug designed to treat postpartum depression (PPD), reducing symptom severity and paving the way for...
Novel AI and Machine Learning Technologies Accelerate RNA Therapeutics Design
Researchers at MIT have developed a machine-learning model named COMET that applies transformer neural networks to analyze and predict lipid nanoparticle (LNP) compositions for optimized delivery...
Advances in Pediatric and Rare Disease Therapies and Diagnostics
Multiple studies and initiatives highlight breakthroughs in pediatric and rare disease care, including the first robotic-assisted pediatric spine surgery performed by Ochsner Children’s,...
New Mechanistic Insights into Neurological and Neurodegenerative Diseases
Research unveils critical molecular mechanisms offering potential therapeutic directions for several neurological disorders. A novel eIF2B activator DNL343 demonstrates efficacy targeting ALS and...
Breakthroughs in Cancer Immunotherapy and Target Identification
Cutting-edge research in oncology reveals promising therapies and molecular targets aimed at overcoming resistance and improving cancer outcomes. Cadonilimab, a next-generation immunotherapy...
Innovations in Battery Materials and Sustainable Energy Technologies
Researchers have reported significant advances in energy storage materials that promise improved battery performance and environmental sustainability. New composites incorporating molybdenum...
Parkinson’s Disease: Digestive Links and Iron Imbalance Emerge
Recent studies have illuminated novel pathological insights into Parkinson’s disease (PD). Researchers have uncovered significant links between digestive health, lifestyle factors, and PD onset...
Gene Therapy and Rare Disease Advances: Resubmissions and Clinical Promises
The gene therapy field progresses amid regulatory challenges and promising clinical data. Stealth BioTherapeutics resubmitted its investigational drug application for Barth syndrome after...